Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Perspective Therapeutics, Inc. CATX

Full chart Compare
Set alert

Price alert · CATX

All alert types
0.87 USD -0.01 (-1.11%)

At closeNov 4, 2026, 4:22 PM EST

0.87 0.00 0.00%

After hours · Nov 4, 4:22 PM ET

0.8374 Day range 0.964
0.8374 52-week range 6.16
YTD
-68.36%
1 year
-62.65%

Financial health

Altman Z-Score

-0.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -2.0×
FY 2016: -56.8×FY 2017: -37.5×FY 2018: -56.7×FY 2019: -115×FY 2020: -137×FY 2021: -6.2×FY 2022: -4.1×FY 2023: -4.7×FY 2024: -2.6×FY 2025: -2.0×
FY 2016 5y median -4.1× FY 2025
P/S 0.0×
FY 2016: 72.2×FY 2017: 41.9×FY 2018: 37.6×FY 2019: 38.8×FY 2020: 43.6×FY 2021: 4.1×FY 2022: 8.2×FY 2023: 154×FY 2024: 141×FY 2025: 0.0×
FY 2016 5y median 8.2× FY 2025
P/B 1.0×
FY 2016: 32.4×FY 2017: 49.3×FY 2018: 35.8×FY 2019: 65.7×FY 2020: 34.3×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 2.9×FY 2024: 0.7×FY 2025: 1.0×
FY 2016 5y median 0.8× FY 2025
P/FCF -2.1×
FY 2016: -54.9×FY 2017: -41.0×FY 2018: -50.0×FY 2019: -96.0×FY 2020: -136×FY 2021: -5.5×FY 2022: -4.2×FY 2023: -5.8×FY 2024: -2.8×FY 2025: -2.1×
FY 2016 5y median -4.2× FY 2025
EV/EBITDA -1.7×
FY 2016: -54.6×FY 2017: -36.7×FY 2018: -52.4×FY 2019: -108×FY 2020: -131×FY 2021: 1.6×FY 2022: -2.8×FY 2023: -5.4×FY 2024: -2.3×FY 2025: -1.7×
FY 2016 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2016: 71.0×FY 2017: 41.5×FY 2018: 36.9×FY 2019: 38.7×FY 2020: 42.7×FY 2021: -1.1×FY 2022: 4.4×FY 2023: 149×FY 2024: 102×FY 2025: 0.0×
FY 2016 5y median 4.4× FY 2025
FCF Yield -46.9%
FY 2016: -1.8%FY 2017: -2.4%FY 2018: -2.0%FY 2019: -1.0%FY 2020: -0.7%FY 2021: -18.2%FY 2022: -24.0%FY 2023: -17.2%FY 2024: -35.4%FY 2025: -46.9%
FY 2016 5y median -24.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 17.6%FY 2017: 31.1%FY 2018: 41.7%FY 2019: 52.9%FY 2020: 50.9%FY 2021: 42.8%FY 2022: 43.7%FY 2023: 100.0%FY 2024: -58.6%FY 2025: 0.0%
FY 2016 5y median 42.8% FY 2025
Operating Margin 0.0%
FY 2016: -132.5%FY 2017: -113.6%FY 2018: -72.2%FY 2019: -35.9%FY 2020: -34.2%FY 2021: -68.5%FY 2022: -168.1%FY 2023: -2855.0%FY 2024: -4594.0%FY 2025: 0.0%
FY 2016 5y median -168.1% FY 2025
Net Margin 0.0%
FY 2016: -129.4%FY 2017: -113.1%FY 2018: -66.3%FY 2019: -33.8%FY 2020: -31.7%FY 2021: -67.4%FY 2022: -198.7%FY 2023: -3243.2%FY 2024: -5452.5%FY 2025: 0.0%
FY 2016 5y median -198.7% FY 2025
ROE -49.8%
FY 2016: -58.1%FY 2017: -133.2%FY 2018: -63.2%FY 2019: -57.1%FY 2020: -25.0%FY 2021: -11.9%FY 2022: -19.7%FY 2023: -61.9%FY 2024: -27.3%FY 2025: -49.8%
FY 2016 5y median -27.3% FY 2025
ROIC -47.2%
FY 2016: -55.2%FY 2017: -119.2%FY 2018: -59.9%FY 2019: -44.8%FY 2020: -22.4%FY 2021: -11.8%FY 2022: -16.5%FY 2023: -46.4%FY 2024: -20.1%FY 2025: -47.2%
FY 2016 5y median -20.1% FY 2025
ROA -38.6%
FY 2016: -50.2%FY 2017: -89.9%FY 2018: -51.5%FY 2019: -37.6%FY 2020: -20.6%FY 2021: -11.3%FY 2022: -18.5%FY 2023: -47.5%FY 2024: -23.2%FY 2025: -38.6%
FY 2016 5y median -23.2% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -0.2%FY 2017: 24.4%FY 2018: 23.5%FY 2019: 32.3%FY 2020: 3.9%FY 2021: 7.4%FY 2022: -49.8%FY 2023: -73.5%FY 2024: 1.4%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -70.0%
FY 2016: -24.1%FY 2017: -6.7%FY 2018: 21.6%FY 2019: 34.1%FY 2020: 1.1%FY 2021: -115.0%FY 2022: -23.2%FY 2023: -349.8%FY 2024: -63.2%FY 2025: -70.0%
FY 2016 FY 2025
EPS (diluted) -13.8%
FY 2016: -28.5%FY 2017: -9.1%FY 2018: 39.8%FY 2019: 33.1%FY 2020: -20.0%FY 2021: -760.6%FY 2022: -20.0%FY 2023: -41.7%FY 2024: -44.7%FY 2025: -13.8%
FY 2016 FY 2025
Free Cash Flow -31.0%
FY 2016: -43.5%FY 2017: 3.4%FY 2018: 9.2%FY 2019: 28.7%FY 2020: 17.8%FY 2021: -147.9%FY 2022: -33.9%FY 2023: -255.6%FY 2024: -91.4%FY 2025: -31.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 9.3×FY 2017: 3.0×FY 2018: 6.5×FY 2019: 3.5×FY 2020: 9.2×FY 2021: 26.2×FY 2022: 17.1×FY 2023: 1.1×FY 2024: 12.7×FY 2025: 5.2×
FY 2016 5y median 12.7× FY 2025
Quick Ratio 5.2×
FY 2016: 9.0×FY 2017: 2.7×FY 2018: 6.1×FY 2019: 3.1×FY 2020: 8.7×FY 2021: 25.6×FY 2022: 16.6×FY 2023: 1.1×FY 2024: 12.7×FY 2025: 5.2×
FY 2016 5y median 12.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 1.0×FY 2017: 0.4×FY 2018: 1.0×FY 2019: 0.4×FY 2020: 2.6×FY 2021: 7.8×FY 2022: 2.4×FY 2023: 0.2×FY 2024: 0.9×FY 2025: 0.3×
FY 2016 5y median 0.9× FY 2025
Interest Coverage -302×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -487×FY 2024: -1392×FY 2025: -302×
FY 2016 5y median -302× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -0.2%FY 2017: -0.2%FY 2018: -0.2%FY 2019: -0.3%FY 2020: -0.3%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31